Debiopharm has entered a strategic research collaboration with NetTargets to design and advance the discovery of novel, synergistic drug combinations for Debiopharm’s next-gen ADCs.
“Imagine a 19th-century business leader debating the ROI of electricity,” Liran Belenzon, co-founder and CEO of BenchSci, ...
A marketing professional recounts their immersive experience at Dinner by Heston in Dubai, viewing it as a live case study in sensory marketing. The author details how Heston Blumenthal masterfully ...
Late for a rock concert, dads’ rules about driving are (legally) broken as the speedometer hits 125 m.p.h. on a highway where ...
A colossal flying reptile with a wingspan near ten metres once dominated ancient skies, challenging dinosaur supremacy and ...
Discover Pitkin, Colorado a quiet high-country town where forest backroads, ghost towns, and forgotten rail tunnels reveal ...
Manufacturing better batteries, faster electronics, and more effective pharmaceuticals depends on the discovery of new ...
An inaugural member of the National Science Foundation’s Accelerating Research Translation program (NSF ART), the University ...
Karen Wigen is Frances and Charles Field Professor in History at Stanford University. Speaking with Srijana Mitra Das at Times Evoke, she discusses th ...
The ISS has “come into its own as a very sophisticated scientific laboratory,” says retired NASA astronaut Scott Kelly, who ...
The kitchen appliance brand was founded in 2009 by Ravi Saxena, who had previously scaled VIP, Sodexo and the Landmark Group, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback